Flow rate calibration to determine cell-derived microparticles and homogeneity of blood components
- PMID: 28774828
- DOI: 10.1016/j.transci.2017.07.016
Flow rate calibration to determine cell-derived microparticles and homogeneity of blood components
Abstract
Background: Cell-derived microparticles (MPs) are currently of great interest to screening transfusion donors and blood components. However, the current approach to counting MPs is not affordable for routine laboratory use due to its high cost.
Aim: The current study aimed to investigate the potential use of flow-rate calibration for counting MPs in whole blood, packed red blood cells (PRBCs), and platelet concentrates (PCs).
Methods: The accuracy of flow-rate calibration was investigated by comparing the platelet counts of an automated counter and a flow-rate calibrator. The concentration of MPs and their origins in whole blood (n=100), PRBCs (n=100), and PCs (n=92) were determined using a FACSCalibur. The MPs' fold-changes were calculated to assess the homogeneity of the blood components.
Results: Comparing the platelet counts conducted by automated counting and flow-rate calibration showed an r2 of 0.6 (y=0.69x+97,620). The CVs of the within-run and between-run variations of flow-rate calibration were 8.2% and 12.1%, respectively. The Bland-Altman plot showed a mean bias of -31,142platelets/μl. MP enumeration revealed both the difference in MP levels and their origins in whole blood, PRBCs, and PCs. Screening the blood components demonstrated high heterogeneity of the MP levels in PCs when compared to whole blood and PRBCs.
Conclusions: The results of the present study suggest the accuracy and precision of flow-rate calibration for enumerating MPs. This flow-rate approach is affordable for assessing the homogeneity of MPs in blood components in routine laboratory practice.
Keywords: Cell-derived microparticle; Flow rate calibration; Packed red blood cell; Platelet concentrate; Transfusion.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Cell-Derived Microparticles in Blood Products from Thalassemic Blood Donors.Lab Med. 2021 Mar 15;52(2):150-157. doi: 10.1093/labmed/lmaa041. Lab Med. 2021. PMID: 32789465
-
Evaluation of microparticles in whole blood by multicolour flow cytometry assay.Scand J Clin Lab Invest. 2013 Apr;73(3):229-39. doi: 10.3109/00365513.2013.769278. Epub 2013 Mar 1. Scand J Clin Lab Invest. 2013. PMID: 23452203
-
Effects of donor age, donor sex, blood-component processing, and storage on cell-derived microparticle concentrations in routine blood-component preparation.Transfus Apher Sci. 2018 Aug;57(4):587-592. doi: 10.1016/j.transci.2018.07.018. Epub 2018 Aug 1. Transfus Apher Sci. 2018. PMID: 30082165
-
Pre-analytical and analytical issues in the analysis of blood microparticles.Thromb Haemost. 2011 Mar;105(3):396-408. doi: 10.1160/TH10-09-0595. Epub 2010 Dec 21. Thromb Haemost. 2011. PMID: 21174005 Review.
-
An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?Transfus Apher Sci. 2015 Oct;53(2):137-45. doi: 10.1016/j.transci.2015.10.010. Epub 2015 Oct 27. Transfus Apher Sci. 2015. PMID: 26596959 Review.
Cited by
-
The in vitro red blood cell microvesiculation exerts procoagulant activity of blood cell storage in Southeast Asian ovalocytosis.Heliyon. 2022 Dec 30;9(1):e12714. doi: 10.1016/j.heliyon.2022.e12714. eCollection 2023 Jan. Heliyon. 2022. PMID: 36632113 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical